SEBI Registered Research Analyst | Wealth Creation Specialist
With over 18 years of experience in Indian capital markets, I provide exclusive research and advisory services to high-net-worth individuals and institutional clients. My approach combines deep fundamental analysis with strategic market insights.
A track record of exceptional performance
Elite Clients
Assets Under Advisory
Average Annual Returns
Years of Excellence
Your trusted partner in wealth creation
SEBI Registered Research Analyst
Registration No: INH000009523
With 18+ years of deep experience in Indian equity markets, I have built a reputation for delivering exceptional research and advisory services to discerning investors. My expertise spans across sectors including technology, pharmaceuticals, infrastructure, and emerging industries.
I hold an MBA in Finance from FMS Delhi and am a CFA charterholder. My research methodology is rooted in rigorous fundamental analysis, complemented by macroeconomic insights and technical indicators. I believe in a concentrated portfolio approach, focusing on quality businesses with sustainable competitive advantages.
Principles guiding our investment approach
We believe in concentrated portfolios of 12-15 high-conviction ideas rather than diversification for its own sake. Each recommendation undergoes rigorous scrutiny.
Our focus is on identifying businesses with sustainable competitive advantages, capable of compounding wealth over 5-10 year horizons.
Capital preservation is paramount. Every investment includes clear risk parameters, stop-loss levels, and position sizing based on conviction and volatility.
Our research goes beyond public information. We conduct primary research, management interactions, and competitor analysis to gain unique insights.
Exclusive research and market analysis
Comprehensive analysis of India's pharma sector transformation - from generics to specialty drugs. Identifying companies positioned to benefit from patent cliffs and biosimilar opportunities.
Access Premium Report →Why diversification can be over-rated. How to build a concentrated, high-conviction portfolio that can generate alpha. Includes detailed case studies and risk management frameworks.
Access Premium Report →Comprehensive analysis of monetary policy impacts, sectoral rotation strategies, and positioning for the next phase of the market cycle. Actionable insights for portfolio allocation.
Access Premium Report →Featured in leading financial publications
"Top 20 Research Analysts in India 2024"
October 2024
Expert Commentary on Pharma Sector Outlook
September 2024
Live Interview - Market Strategy for HNI Investors
August 2024
Column: Concentrated Investing Strategies
July 2024
Exclusive research and advisory solutions
₹45,000/quarter
₹2,50,000/year
Custom/pricing
What our elite clients say
"Deepak's research is unparalleled in depth and quality. His concentrated portfolio approach has delivered exceptional returns for my family office. The personalized attention and strategic insights are worth every rupee of the premium."
"Working with Deepak has been transformative for our wealth creation journey. His pharma sector calls have been exceptional - we're up over 300% in just under 3 years. The level of research and conviction is remarkable."
"As someone managing a ₹50Cr+ portfolio, I need research that's sophisticated and actionable. Deepak delivers both. His concentrated approach and risk management framework align perfectly with my investment philosophy."
"The Platinum Advisory service is exceptional. Having direct access to Deepak for portfolio decisions has been invaluable. His infrastructure sector thesis played out exactly as predicted. Truly premium service for serious investors."
Fully regulated and compliant
Join 250+ elite investors who trust our premium research